Results 181 to 190 of about 2,212,418 (287)

Systemic Arterial Hypertension and Factors Associated with Blood Pressure Dysregulation in Companion Animals. [PDF]

Vet Sci
de Sousa FG, Queiroz FSF, Muzzi RAL, Veado JCC, Beier SL.   +4 more
europepmc   +1 more source

Spotlight commentary: Drug therapy in hypoxic environments: From aerospace models to high‐altitude clinical pharmacology

British Journal of Clinical Pharmacology, EarlyView.
Martin Bobek, Jakov Kožić, Feđa Džubur   +2 more
wiley   +1 more source

Multivariate linear regression to predict association of non‐invasive arterial stiffness with cardiovascular events

ESC Heart Failure, Volume 12, Issue 2, Page 1141-1150, April 2025.
Abstract Background Arterial stiffness is a crucial factor in determining an increase in systolic blood pressure and pulse pressure and can also predict the development of cardiovascular disease (CVD). The purpose of this study was to examine the relationship between arterial stiffness and future CVD.
Susan Darroudi, Mostafa Eslamiyeh, Amin Mansoori, Eisa Nazar, Maryam Alinezhad‐Namaghi, Reza Rezvani, Majid Ghayour‐Mobarhan, Habibollah Esmaily, Mohsen Moohebati, Gordon A. Ferns, Mark Ghamsary   +10 more
wiley   +1 more source

[Adherence, barriers, and facilitators for the treatment of systemic arterial hypertension: rapid review of evidenceAdhesión, obstáculos y elementos facilitadores en relación con el tratamiento de la hipertensión: revisión rápida de la evidencia]. [PDF]

Rev Panam Salud Publica, 2023
da Silva LALB, de Melo RC, Toma TS, de Araújo BC, Luquine CD, Milhomens LM, de Bortoli MC, Barreto JOM.   +7 more
europepmc   +1 more source

Left ventricle remodeling by CMR in treated patients with primary aldosteronism and primary systemic arterial hypertension. [PDF]

PLoS One
Reiser CS, Assuncao AN, Araujo-Filho JAB, Dantas RN, Bortolotto LA, Parga-Filho JR.   +5 more
europepmc   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Experiences of access and use of primary health care by users with systemic arterial hypertension. [PDF]

Rev Esc Enferm USP
Ribeiro AMVB, Vilasbôas ALQ, de Almeida PF.   +2 more
europepmc   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Multimodal Data Integration Enhance Longitudinal Prediction of New-Onset Systemic Arterial Hypertension Patients with Suspected Obstructive Sleep Apnea. [PDF]

Rev Cardiovasc Med
Yang Y, Jiang H, Yang H, Hou X, Wu T, Pan Y, Xie X.   +6 more
europepmc   +1 more source

Effect of systemic arterial hypertension and use of antiproteinuric drug in induction therapy for lupus nephritis. [PDF]

Einstein (Sao Paulo), 2020
Matta EG, Rubini DA, Araújo NC.
europepmc   +1 more source